INSTAND EQA Scheme Program 2026

Recent Posts

Imtakt has released its latest collection of HPLC application notes and technical resources, featuring separation

Imtakt continues to expand its library of HPLC and LC-MS application data, providing laboratories with

Introducing the eplex RP3 Control M530 for Respiratory Testing MMQCI is pleased to introduce the

PM Separations is pleased to announce the availability of the Nitroso-Mix 8 Solution from HPC

We are pleased to announce the release of the new INSTAND EQA Scheme Program 2026.

The Program has been optimised to meet the highest quality standards for you and your laboratory. The new programs are the following:

Clinical Chemistry
- EQAS 180 Urine Chemistry Aminolaevulinic acid / Porphobilinogen
Molecular Genetics
- EQAS 727 NIP T – Determination of fetal RhD status
- EQAS 752 ctDNA Tumor Panel
- EQAS 822 CD19 CAR-T- Cells (quantitative)
EQA Schemes relevant to POCT-testing
- Multiple EQA Schemes include analytes relevant to Point-Of-Care Testing (POCT) and are generally suitable for participation using corresponding POCT systems. Detailed information can be found on the pages 8-10 of the downloaded catalogue below.

In the attached files, you will find the INSTAND EQA Scheme Program 2026

We look forward to making your 2026 INSTAND QAP stress free and seamless.

The Quality Assurance team

We are a proud Australian family-owned business and focus on our ability to be nimble and adjust ourselves to the needs of our clients.